What type and size of suture material are recommended for facial skin closure after a facelift?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Facial Suture Selection After Facelift

For facial skin closure after facelift surgery, use 5-0 or 6-0 absorbable monofilament sutures (poliglecaprone-25 or polyglactin 910) placed as continuous subcuticular sutures, which provide equivalent cosmetic outcomes to nonabsorbable sutures while eliminating the need for suture removal.

Suture Material and Size

Absorbable vs. Nonabsorbable Sutures

  • Absorbable sutures (5-0 or 6-0) demonstrate equivalent aesthetic and clinical outcomes compared to nonabsorbable sutures for facial skin closure, with no statistically significant differences in cosmesis scales, infections, wound dehiscence, or scarring 1.

  • 5-0 poliglecaprone-25 provides cosmetically identical results to 6-0 polypropylene in facial closures, with 85% of cases showing no difference between the two materials at 4-month follow-up 2.

  • 5-0 coated polyglactin 910 (Vicryl Rapide) produces equivalent long-term cosmetic results to 5-0 polypropylene in facial wound closures, with no difference in scar formation at 6-month follow-up 3.

Recommended Suture Specifications

  • Primary choice: 5-0 poliglecaprone-25 or 5-0 polyglactin 910 for superficial facial closure 2, 3.

  • Alternative sizing: 6-0 polypropylene or 6-0 absorbable sutures can be used for very fine approximation, though 5-0 absorbable provides comparable results 2.

  • These absorbable sutures retain 50-75% of their original tensile strength after 1 week, providing adequate wound support during the critical healing phase 4.

Suture Technique

Continuous vs. Interrupted Sutures

  • Continuous subcuticular sutures significantly reduce superficial wound dehiscence (RR 0.08; 95% CI 0.02 to 0.35) compared to interrupted transcutaneous sutures 4.

  • No difference exists in surgical site infection rates or hospital stay length between continuous and interrupted techniques 4.

  • The continuous technique provides better wound edge sealing to prevent exogenous bacterial invasion while maintaining adequate perfusion when not overtightened 4.

Layered Closure Approach

  • Deep dermal layer: 4-0 or 5-0 poliglecaprone-25 for subcutaneous tissue approximation 3.

  • Superficial layer: 5-0 poliglecaprone-25 or polyglactin 910 as continuous subcuticular suture using the remaining absorbable suture from deep closure 2, 3.

  • This approach is cost-effective as it eliminates the need for separate nonabsorbable suture material and subsequent removal 2, 3.

Clinical Advantages of Absorbable Sutures

  • Elimination of suture removal saves surgeon time and reduces patient anxiety and discomfort 3.

  • No wound complications (infection, hematoma, dehiscence) were observed with absorbable sutures in facial closures 2, 3.

  • Comparable ease of handling to nonabsorbable materials when using modern monofilament absorbable sutures 2, 3.

Common Pitfalls to Avoid

  • Avoid overtightening continuous sutures, as this can strangulate wound edges and compromise perfusion 4.

  • Do not add adhesive strips (steri-strips) routinely, as they provide no additional benefit in reducing scar width or improving cosmetic outcomes when proper subcuticular sutures are used 4.

  • Tissue adhesives alone are inferior to sutures, with significantly higher wound dehiscence rates (RR 3.35; 95% CI 1.53 to 7.33) 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.